A study suggested that the over-expression of RORC would promote Th17-mediated COAD.[63] Using the immunohistochemistry method, Yoshida et al found that a high RORC/CD3 ratio was significantly associated with lymph node metastasis and a poor prognosis.[64]. Here, RORC is linked to metastatic malignant neoplasm in the lymph nodes.